Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WHWK
2576
Whitehawk Therapeutics
WHWK
$190M
| $641K | ﹤0.01% |
439,222
-104,500
| -19% | -$194K |
|
|
KW
2577
DELISTED
Kennedy-Wilson Holdings
KW
| $640K | ﹤0.01% |
65,800
-223,100
| -77% | -$2.09M |
|
|
ACR
2578
ACRES Commercial Realty
ACR
$124M
| $639K | ﹤0.01% |
50,094
-32,178
| -39% | -$427K |
|
|
NFGC
2579
New Found Gold
NFGC
$522M
| $637K | ﹤0.01% |
+225,119
| New | +$793K |
|
2580
Greenwich LifeSciences
GLSI
$198M
| $637K | ﹤0.01% |
36,900
-600
| -2% | -$8.77K |
|
2581
Dimensional US Small Cap ETF
DFAS
$15.4B
| $637K | ﹤0.01% |
+10,600
| New | +$638K |
|
2582
iShares Russell Top 200 Value ETF
IWX
$3.98B
| $636K | ﹤0.01% |
8,500
-10,700
| -56% | -$800K |
|
2583
Entrada Therapeutics
TRDA
$264M
| $636K | ﹤0.01% |
+44,600
| New | +$634K |
|
|
HITI
2584
High Tide
HITI
$186M
| $634K | ﹤0.01% |
287,100
-110,900
| -28% | -$259K |
|
2585
Champions Oncology
CSBR
$74.5M
| $634K | ﹤0.01% |
122,591
-2,100
| -2% | -$10.2K |
|
|
ICAD
2586
DELISTED
iCAD Inc
ICAD
| $632K | ﹤0.01% |
486,190
-4,922
| -1% | -$7.58K |
|
2587
Dimensional US Core Equity 2 ETF
DFAC
$47.9B
| $632K | ﹤0.01% |
+19,600
| New | +$618K |
|
2588
Insteel Industries
IIIN
$593M
| $632K | ﹤0.01% |
20,400
+200
| +1% | +$6.56K |
|
|
MNTX
2589
DELISTED
Manitex International, Inc.
MNTX
| $629K | ﹤0.01% |
142,073
+16,433
| +13% | +$95.2K |
|
2590
Vanguard Financials ETF
VFH
$13.5B
| $629K | ﹤0.01% |
6,300
-5,100
| -45% | -$509K |
|
2591
Betterware México
BWMX
$634M
| $628K | ﹤0.01% |
43,000
| – | – |
|
2592
Tompkins Financial
TMP
$1.43B
| $627K | ﹤0.01% |
12,830
-900
| -7% | -$41.5K |
|
|
AD
2593
Array Digital Infrastructure
AD
$3.01B
| $625K | ﹤0.01% |
11,200
-27,900
| -71% | -$1.23M |
|
2594
iShares US Equity Factor ETF
LRGF
$3.58B
| $624K | ﹤0.01% |
11,200
-9,400
| -46% | -$505K |
|
|
RAPT
2595
DELISTED
RAPT Therapeutics
RAPT
| $622K | ﹤0.01% |
25,488
+13,238
| +108% | +$611K |
|
|
PMD
2596
DELISTED
Psychemedics Corporation
PMD
| $622K | ﹤0.01% |
256,963
-2,900
| -1% | -$7.37K |
|
2597
Citizens
CIA
$239M
| $617K | ﹤0.01% |
226,794
-5,000
| -2% | -$12.6K |
|
2598
BioLife Solutions
BLFS
$1.53B
| $615K | ﹤0.01% |
+28,700
| New | +$557K |
|
2599
Perspective Therapeutics
CATX
$332M
| $615K | ﹤0.01% |
61,660
+58,485
| +1,842% | +$846K |
|
|
EHAB
2600
DELISTED
Enhabit
EHAB
| $615K | ﹤0.01% |
68,900
+58,500
| +563% | +$559K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.